enVVeno Medical Corp(NVNO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

enVVeno Medical Corp (NVNO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NVNO is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.4m in revenue and is scored on the micro-cap board instead. Top institutional holders of NVNO by reported 13-F value include KINGDON CAPITAL MANAGEMENT, L.L.C., CM Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NVNO trades on the Nasdaq exchange and files with the SEC under CIK 1661053. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NVNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for enVVeno Medical Corp directly from SEC EDGAR.

Net Income

$-3.6M

NVNO key financials by period

enVVeno Medical Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 201910-K$31.2K$-7.6M
FY 201810-K$186.6K$-13.0M
FY 201710-K$422.1K$-7.8M

Institutions holding NVNO

Institutional investors reporting a position in enVVeno Medical Corp on SEC Form 13F.
InstitutionSharesValueReported
KINGDON CAPITAL MANAGEMENT, L.L.C.36,166$387.3K2026-06-30
CM Management35,714$382.5K2026-06-30
VANGUARD CAPITAL MANAGEMENT6,287$67.4K2026-06-30
JPMORGAN CHASE5,208$59.1K2026-06-30
VANGUARD FIDUCIARY2,184$23.4K2026-06-30
Westside Investment Management1,525$16.3K2026-06-30
Mirae Asset Global Investments , Ltd.539$5.8K2026-06-30
BlackRock414$4.4K2026-06-30
Tower Research Capital (TRC)331$3.5K2026-06-30
WELLS FARGO & COMPANY114$1.2K2026-06-30
NVNO

enVVeno Medical Corp

NVNO
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.4M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-3.60M

EPS (Diluted)

Q2 2026
EDGAR

$-5.37

ROIC

Q2 2026
EDGAR

-73.5%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…